- Home
- STRO vs HTCR Comparison
STRO vs HTCR Comparison
Compare STRO & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- HTCR
- Stock Information
- Founded
- STRO 2003
- HTCR 2009
- Country
- STRO United States
- HTCR Japan
- Employees
- STRO N/A
- HTCR N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- HTCR EDP Services
- Sector
- STRO Health Care
- HTCR Technology
- Exchange
- STRO Nasdaq
- HTCR Nasdaq
- Market Cap
- STRO 50.0M
- HTCR 48.1M
- IPO Year
- STRO 2018
- HTCR 2022
- Fundamental
- Price
- STRO $0.52
- HTCR $0.59
- Analyst Decision
- STRO Buy
- HTCR
- Analyst Count
- STRO 7
- HTCR 0
- Target Price
- STRO $6.83
- HTCR N/A
- AVG Volume (30 Days)
- STRO 1.4M
- HTCR 72.3K
- Earning Date
- STRO 05-12-2025
- HTCR 05-13-2025
- Dividend Yield
- STRO N/A
- HTCR 6.69%
- EPS Growth
- STRO N/A
- HTCR N/A
- EPS
- STRO N/A
- HTCR N/A
- Revenue
- STRO $62,043,000.00
- HTCR $30,407,229.00
- Revenue This Year
- STRO N/A
- HTCR N/A
- Revenue Next Year
- STRO $1.29
- HTCR N/A
- P/E Ratio
- STRO N/A
- HTCR N/A
- Revenue Growth
- STRO N/A
- HTCR 39.19
- 52 Week Low
- STRO $0.54
- HTCR $0.55
- 52 Week High
- STRO $5.17
- HTCR $3.38
- Technical
- Relative Strength Index (RSI)
- STRO 29.82
- HTCR 28.10
- Support Level
- STRO $0.54
- HTCR $0.56
- Resistance Level
- STRO $0.78
- HTCR $0.72
- Average True Range (ATR)
- STRO 0.09
- HTCR 0.08
- MACD
- STRO 0.02
- HTCR 0.00
- Stochastic Oscillator
- STRO 0.00
- HTCR 10.28
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About HTCR Heartcore Enterprises Inc.
HeartCore Enterprises Inc is a software development company. It provides software through two business units. The first business unit includes a customer experience management business that has been in existence for 12 years. The customer experience management platform includes marketing, sales, service and content management systems, as well as other tools and integrations, that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, its DX division, is a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises.